Evidence map›Paper›PMID 36654960›Full record

ArticleGland surgery2022

Effect of

Xingquan Wang, Dewang Su, Yaqing Wei, Shilin Liu, Shengyu Gao, Hao Tian, Weiwei Wei

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Gland surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Xingquan Wang *Department of General Surgery, First Affiliated Hospital of Jiamusi University, Jiamusi, China.
Dewang Su *Department of General Surgery, First Affiliated Hospital of Jiamusi University, Jiamusi, China.
Yaqing WeiDepartment of Infectious Diseases, City Center Hospital of Jiamusi City, Jiamusi, China.
Shilin LiuDepartment of Rheumatology, First Affiliated Hospital of Jiamusi University, Jiamusi, China.
Shengyu GaoDepartment of General Surgery, First Affiliated Hospital of Jiamusi University, Jiamusi, China.
Hao TianDepartment of General Surgery, First Affiliated Hospital of Jiamusi University, Jiamusi, China.
Weiwei WeiDepartment of General Surgery, First Affiliated Hospital of Jiamusi University, Jiamusi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Thyroid blood vessels and nerves are rich, and their anatomical and physiological structures are complex. Surgery often fails to eradicate the tumor, which has a serious negative impact on the surgical outcomes and patient prognosis. Therefore, it is important to accurately predict the recurrence rate of thyroid cancer. Methods: Based on bioinformatics analysis, the highly expressed transcription factors and differential genes in thyroid carcinoma (THCA) were obtained. Kaplan-Meier survival analysis was used to analyze the clinical effects of Results: Conclusions: We identified

Indexed as

diagnostic biomarkerGATAD1potential therapeutic targetSRRM2thyroid carcinoma (THCA)

Identifiers

PMID36654960
PMCPMC9841002

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.